Peter Brown
BACK TO people
Associate
Peter is an Associate of James & Wells and is based in our
Hamilton office. He specialises in IP protection in the
food/beverage, pharmaceutical, and life science industries.
Expertise
Qualifications
- PhD, University of Auckland - Structural Biology and Type II
Diabetes Drug Development (2007)
- BSc (Hons), University of Otago - Genetics, Plant Biotechnology
(2002)
- Registered Patent Attorney
Peter joined James & Wells in 2008 after gaining research
experience at the University of Auckland during his PhD and
postdoctoral studies in collaborative projects with biotech and
pharmaceutical companies. This has given Peter an excellent
grasp on the issues faced by scientists who need publications, and
the goals of industry to commercialise.
Peter now works closely with clients in the food and beverage
industry to develop sound IP strategies to help them achieve their
commercial goals. Peter is of the opinion that IP protection needs
to play a bigger role in leveraging our competitive advantages in
the food industry, which is often in the innovative way we do
things to compete on the global scale. Peter writes regular
articles on the subject of intellectual property protection in the
food industry, including articles in the Food New Zealand
magazine. He is also a speaker at conferences on this
subject.
Besides the food industry, Peter also maintains a key interest
in working on behalf of a number of New Zealand and overseas based
biotech and veterinary companies, also drawing on his science
background.
Associations
New Zealand Institute of Food Science and Technology
(NZIFST)
NZBio
AusBiotech
Royal Society of New Zealand
Fellow of the New Zealand Institute of Patent Attorneys (NZIPA)
PETER'S RECENT CONTRIBUTIONS
Recipe for Success. more
...Kiwi tentmaker goes global. more
Submissions to the Australian patent amendment (human genes and biological materials) bill 2010. more
...How IP protection can be valuable to a NZ business?. more
Potential changes in gene patentability in the United States. more
EPO rejects swiss-type claims for protecting 2nd pharmaceutical uses. more
Government incentives for scientific R & D look promising. more
IN PERSON: PETER BROWN, PATENT ATTORNEY PENDING. more